1. JAK‐STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI‐ALCL PATHOGENESIS?. (12th June 2019) Authors: Laurent, C.; Nicolae, A.; Laurent, C.; Le Bras, F.; Haioun, C.; Fataccioli, V.; Amara, N.; Adélaïde, J.; Guille, A.; Schiano De Colella, J.; Tesson, B.; Traverse‐Glehen, A.; Chenard, M.; Mescam, L.; Moreau, A.; Chassagne‐Clément, C.; Somja, J.; Escudié, F.; André, M.; Martin, N. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PRE-TRANSPLANT TREATMENT OF HEPATISPLENIC T-CELL LYMPHOMA (GAMMA-DELATA): A PEDIATRIC CASE REPORT. (October 2022) Authors: Abel, M.; Nazon, C.; Spiegel-Bouhadid, A.; Salmon, A.; Fornecker, L.; Nicolae, A.; Paillard, C. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOES THE PRESENCE OF ARTERIAL HYPERTENSION INFLUENCE THE PRESCRIPTION OF ANTIPLATELET DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS?. (June 2018) Authors: Diaconu, C.; Gaman, M.; Dobrica, E.; Cozma, M.; Dediu, G.; Gaman, A.; Arsene, A.; Dragoi, C.; Nicolae, A.; Velescu, B.; Paraschiv, B.; Tincu, R.; Iancu, M. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BETABLOCKERS' PRESCRIPTION PATTERNS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR COMORBIDITIES. (June 2018) Authors: Diaconu, C.; Gaman, M.; Dobrica, E.; Cozma, M.; Dediu, G.; Gaman, A.; Arsene, A.; Nicolae, A.; Dragoi, C.; Velescu, B.; Paraschiv, B.; Tincu, R.; Iancu, M. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗